Keywords: Diagnosis/Prediction, Lung
Motivation: Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer(NSCLC) facilitates the selection of clinical treatment options.
Goal(s): To predict EGFR mutation status in NSCLC using MRI-based radiomics and explore the optimal sequence for prediction.
Approach: 117 patients (72 with mutant, 45 with wild-type) were included. ZTE, T2W-FS, and DWI sequences were selected for radiomics features extraction. The abilities of the features to predict EGFR mutation status were analyzed and compared.
Results: The radiomics signature of DWI showed the best diagnostic performance in both the training and validation cohorts , which yielded an AUC of 0.873 in the validation cohort.
Impact: DWI radiomics signature can be used as a noninvasive tool for predicting EGFR mutation status in NSCLC, which is helpful to guide therapeutic strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords